J&J Ordered to Pay $10M Topamax Verdict

A Philadelphia jury decided Janssen Pharmaceuticals must pay over $10 million in damages to the parents of a five-year-old boy.
HOUSTON - Nov. 18, 2013 - PRLog -- A Philadelphia jury decided Janssen Pharmaceuticals must pay over $10 million in damages to the parents of a five-year-old boy who developed cleft lip and other birth defects after being exposed to the anticonvulsant drug Topamax during his mother’s pregnancy.

This is the second multi-million dollar verdict in the past three weeks for the Houston law firm of Clark, Love & Hutson against Janssen Pharmaceuticals, Inc., a subsidiary of Johnson and Johnson, the manufacturer of Topamax.

According to partners Scott A. Love and Shelley V. Hutson, who tried the two cases, the verdicts confirm that, “Janssen knew about Topamax’s serious risk of causing birth defects years before these mothers were prescribed the drug, but did not advise physicians of those risks. Instead, Janssen elected to continue to market its billion dollar drug.”

“Clearly, the jury appreciated that these children suffered debilitating birth defects that will require numerous surgeries, as well as severe psychological injuries, that could have been avoided,” said Shelley V. Hutson.

The case is styled GURLEY ET AL. VS ORTHO-MCNEIL-JANSSEN PHARMACEUTICAL,110502251, Court of Common Pleas, Philadelphia County, Pennsylvania and was tried by attorneys Shelley V. Hutson, Blake A. Deady, and Scott A. Love.

Contact
Clark, Love & Hutson, G.P.
***@triallawfirm.com
713.757.1400
End
Email:***@triallawfirm.com Email Verified
Tags:Lawsuit, Topamax
Industry:Business, Legal
Location:Houston - Texas - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Nov 18, 2013



Like PRLog?
9K2K1K
Click to Share